Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
IL-21 expression is increased in the gut of patients with colitis-associated colon cancer, and genetic ablation or antibody neutralization of IL-21 reduces tumor size and inflammation in mice treated with dextran sulfate sodium and azoxymethane.
Main Authors: | Stolfi, Carmine, Rizzo, Angelamaria, Franzè, Eleonora, Rotondi, Angela, Fantini, Massimo Claudio, Sarra, Massimiliano, Caruso, Roberta, Monteleone, Ivan, Sileri, Pierpaolo, Franceschilli, Luana, Caprioli, Flavio, Ferrero, Stefano, MacDonald, Thomas T., Pallone, Francesco, Monteleone, Giovanni |
---|---|
Format: | Online |
Language: | English |
Published: |
The Rockefeller University Press
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201207/ |
Similar Items
-
Lesional Accumulation of CD163-Expressing Cells in the Gut of Patients with Inflammatory Bowel Disease
by: Franzè, Eleonora, et al.
Published: (2013) -
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis
by: De Simone, Veronica, et al.
Published: (2015) -
A functional role for Smad7 in sustaining colon cancer cell growth and survival
by: Stolfi, C, et al.
Published: (2014) -
Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives
by: Stolfi, Carmine, et al.
Published: (2012) -
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer
by: Stolfi, Carmine, et al.
Published: (2012)